Professor Jacob SchechterTOP Israeli Oncologist – Melanoma and Skin Cancer Institute

Position: Chairman of the Melanoma and Immunooncology Institute Ella Lamelbaum 

Hospital: Sheba Medical Center, Israel

Prof. Schechter is in the Forbes list of the best Israeli doctors

Qualified Medical Consultation Online, Second Opinion on Melanoma Convectional and Innovative Treatment

Ask Doctor


Qualified Medical Consultation

Early and Metastatic stages of: Melanoma of soft tissueMelanoma retina, Uveal melanoma, (Eye melanoma), Mucosal melanoma, Superficial, Nodular, Acrolenti-Ginous, Amelanotic (pigmentless) Melanoma and others.

Send Your Medical Files               Book Consultation Now

  • 1969-1976 – School of Medicine, Hebrew University, Jerusalem
  • 1982-1986 – Specialization in Oncology, Beilinson Hospital, Rabin Medical Center, Petah Tikva

Dr. Jacob Schechter Experience:

Since 2014 till present Prof. Schechter is a Chairman of the Ella Lamelbaum Institute for Melanoma and Immunooncology 

Institute Overview:

  • Under Prof. Schechter’s guidance, the Melanoma and Immunooncology Institute at Sheba Academic Medical Center offers a unique approach to melanoma treatment.
  • The institute conducts studies aimed at developing future treatment prospects for melanoma.
  • Collaborations with the Advanced Technologies Center and the Department of Plastic Surgery and Surgical Oncology facilitate patient observation, innovative surgical methods, and diverse treatment approaches.

Cutting-Edge Therapy:

  • The institute offers the most promising experimental therapy for melanoma.
  • Israeli Melanoma Institute is among the few institutions worldwide, alongside the National Institute of Health (NIH) in the United States, known for such advanced treatment.

Academic Activity:

  • Dr. Schechter is a Chairman of the Department of Oncology, Sackler School of Medicine, Tel Aviv University
  • Member of the Israeli Society of Oncology and Clinical Radiotherapy
  • Head of the Israeli Melanoma Society Forum

Prof. Schechter has carried out about 100 epidemiological studies published in leading medical journals.

Some of dr. Schechter publications: 

  • Pembrolizumab versus ipilimumab in advanced melanoma. Epub 2019 Jul 22.PMID: 31345627 Clinical Trial
  • Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science. 2021 Feb
  • Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915). Clin Oncol. 2023 Jan, Epub 2022 Sep 26.


Call-Center for an appointment at leading doctors of IsraelContact us if you are not sure about your health condition or diagnosis / faced with the choice of a treatment option / need second opinion of a reputable Israeli doctor  / a reliable, clear medical advice / second opinion on biopsy results / MRI / PET / CT scan / advanced medical treatment in best hospitals in Israel.
We will promptly coordinate a doctor consultation and medical treatment in Israel.
Tel / Whatsapp / Viber +972 54 803 45 32
*Authorized by Israel Ministry of Health
מס פניה:#622301

In Israel you'll find

  • ADVANCED Medical Standard
  • INNOVATIONS (6th place globally)
  • Newest FDA Protocols
  • HIGH Treatment Outcomes Rate

!מבקרים באתר היקרים, אנא שימו לב

.אנחנו חברה תיירות מרפא. אנו נותנים שרות פרטי לתיירים בלבד